RTI Biologics, ENTrigue Surgical, Inc. Announce Development and Supply Agreement For Tutoplast(R)-Processed Tissues

Published: Dec 15, 2008

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announced today that it has signed an agreement to provide biologic implants to ENTrigue Surgical, Inc., the Texas-based manufacturer of medical devices and instrumentation for the surgical treatment of conditions of the ear, nose and throat (ENT).

Back to news